Value of body-worn sensors to assess functioning in the follow-up of patients with a hip fracture

ISRCTN ISRCTN21642113
DOI https://doi.org/10.1186/ISRCTN21642113
Submission date
11/02/2022
Registration date
30/01/2023
Last edited
27/05/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Osteoporotic hip fracture treatment remains challenging both due to the increasing age of the population and the high number of complications including death. As a consequence, multiple guidelines have been developed during the last decades to improve the care for geriatric hip fracture patients. Early surgery (surgery within 24 to 48 hours after admission), as well as early mobilization after surgery allowing for full weight bearing, have been proven to be important process indicators. To evaluate the postoperative functionality of geriatric hip fracture patients, both patient-reported, as well as observer-based measurement methods, are used. The aim of this study is to explore the added value of wearable technology for evaluating postoperative functionality through continuous measurement of posture and movement.
There are two primary study aims:
1. To describe patient-reported and observer-based evaluations of functional status during hospitalization for geriatric hip fracture treatment and at follow-up consultations at 6 weeks, 3 months and 6 months after surgery.
2. To evaluate the responsiveness of patient-reported, observer-based and sensor-provided functional assessment methods.

Who can participate?
Patients undergoing surgical repair for proximal femoral fracture, aged 50 years or over, allowed to execute any form of weight bearing

What does the study involve?
Detailed longitudinal follow-up of functioning using patient-reported, sensor-based and observer-based assessments of functioning up to 6 months after surgery.

What are the possible benefits and risks of participating?
Participating will help with the development of feasible, reliable and valid assessments of functioning. This will help with the detection of unfavourable functional outcomes in patients undergoing hip fracture repair. There are no risks associated with this study

Where is the study run from?
1. University Hospitals Leuven (Belgium)
2. KU Leuven (Belgium)

When is the study starting and how long is it expected to run for?
April 2021 to April 2024

Who is funding the study?
1. University Hospitals Leuven (Belgium)
2. KU Leuven (Belgium)

Who is the main contact?
Prof Dr An Sermon (Belgium)
an.sermon@uzleuven.be

Contact information

Prof An Sermon
Principal Investigator

Herestraat 49
Leuven
3000
Belgium

Phone +32 (0)16344592
Email an.sermon@uzleuven.be
Mr Thijs Swinnen
Scientific

Herestraat 49
Leuven
3000
Belgium

Phone +32 (0)16 34 05 13
Email thijs.swinnen@uzleuven.be
Ms Elga Nijs
Public

Herestraat 49
Leuven
3000
Belgium

Phone +32 (0)1642364
Email elga.nijs@uzleuven.be

Study information

Study designSingle-centre prospective interventional study with retrospective use of Good Clinical Practice data
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeOther
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleAdded value of a technology-driven assessment of functioning in patients with proximal femoral fracture
Study acronymIMU
Study objectives1. To describe and compare patient-reported, observed, and technology-measured assessments of physical function (physical activity and functionality) during hospitalization and during follow-up consultations up to 6 months over time in patients with proximal femoral fracture.
2. To compare the responsiveness of patient-reported, observed, and technology-measured assessments of physical functioning (physical activity and functionality) in patients with proximal femoral fracture.
Ethics approval(s)Approved 21/05/2021, Ethics Committee Research UZ/KU Leuven (Herestraat 49, 3000 Leuven, Belgium; +32 (0)16 34 86 00; ec@uzleuven.be), ref: S65163
Health condition(s) or problem(s) studiedSurgical repair of proximal femur fractures in patients older than 50 years
InterventionThis study is a monocentric prospective study with an intervention (additional use of one sensor on the chest without health risk to the patient), with retrospective use of Good Clinical Practice (GCP) data collected from 01-01-2021 to 22/04/2021 (physical activity measured by one similar sensor on the leg, the Timed-Up-and-Go test and observation of functioning during the hospitalization period).

After surgery, a sensor will be attached to the affected leg and the chest as soon as possible. This sensor measures physical activity throughout the hospitalization period. These sensors will be re-installed during a consultation at 6 weeks, 3 and 6 months after surgery to measure physical activity for at least 7 days at home. In addition, participants complete several questionnaires: Global Ratings of Perceived Effect, Parker Mobility Score, Pain Assessment, Fall Efficacy Scale and questionnaires on the ease of use of sensor measurements.

In addition, the researchers will perform the following measurements: Harris Hip Score, the Morton Mobility Index (DEMMI) and the timed up-and-go (TUG) test.

Finally, the researchers will also collect general information from the patients' medical records, as well as information about the surgery and rehabilitation.
Intervention typeMixed
Primary outcome measure1. Patient-reported functional status assessed using the Harris Hip Score: Pre-surgery status at day 9 after surgery; week 6, and months 3 and 6 after surgery
2. Observed functional status assessed using DEMMI at Day 9, week 6, and months 3 and 6 after surgery
3. Performance-based functional status assessed using TUG test at Day 9, week 6, and months 3 and 6 after surgery
4. Physical activity assessed using activity sensors during hospitalisation, at least 7 days at home, week 6, and months 3 and 6
5. Health status assessed using Global ratings of perceived effect at week 6, and months 3 and 6
Secondary outcome measuresThe following outcomes will be extracted from the patients' medical records or questioned to the patient during hospitalisation and at day 9, week 6, months 3 and 6 after the surgery:
1. Pre-surgery status assessed at day 9 after surgery
2. Demographics and anthropometrics
3. Medical history
4. Time of admission, surgery
5. Surgical procedure, history of hip surgery
6. Time to start mobilization and gait rehabilitation, number and timing of physical therapy sessions
7. Date of admission, medical discharge and discharge (calculation of admission time, admission time until medical discharge)
8. Mental status assessed using a categorical clinician score (electronic patient record), at all time points
9. Comorbidity assessed using the American Society for Anaesthesiologists Physical Status classification
10. Comorbidity assessed using the Charlson Comorbidity Index
11. Medication schedule
12. Fear of falling assessed using the Fall Efficacy Scale
13. Mortality
14. Pain assessed using Numerical Rating Scale
15. Participation assessed using the Parker Mobility Score
16. Feasibility of sensor measurements assessed using Numerical Rating Scale
Overall study start date09/04/2021
Completion date26/04/2024

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants65
Key inclusion criteria1. Surgical treatment of proximal femur fracture
2. Age >50 years
3. Immediate weight bearing allowed after surgery
Key exclusion criteria1. Revision surgery (affected leg)
2. Pathological fracture
3. Preoperative bedridden, not able to stand up
4. Current COVID-19 infection or other infectious risk requiring isolation
5. Polytrauma/multiple injuries
Date of first enrolment21/05/2021
Date of final enrolment21/05/2025

Locations

Countries of recruitment

  • Belgium

Study participating centre

UZ Leuven
Herestraat 49
Leuven
3000
Belgium

Sponsor information

Universitair Ziekenhuis Leuven
Hospital/treatment centre

Herestraat 49
Leuven
3000
Belgium

Phone +32 (0)16 34 86 00
Email ec@uzleuven
Website https://www.uzleuven.be/en
ROR logo "ROR" https://ror.org/0424bsv16

Funders

Funder type

University/education

KU Leuven
Private sector organisation / Universities (academic only)
Alternative name(s)
Katholieke Universiteit Leuven
Location
Belgium

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planData are available on reasonable request from the corresponding study lead, Prof Dr An Sermon (an.sermon@uzleuven.be), but not publicly, given possible intellectual property affairs related to raw sensor data processing or classification algorithms in this specific population.

Editorial Notes

27/05/2025: The overall end date was changed from 12/07/2024 to 26/04/2024.
16/01/2025: The following changes were made to the trial record:
1. The overall end date was changed from 21/05/2025 to 12/07/2024.
2. The intention to publish date was changed from 31/12/2024 to 31/12/2025.
3. The plain English summary was updated to reflect these changes.
24/06/2022: Trial's existence confirmed by Ethics Committee Research UZ/KU Leuven.